Avara Pharmaceutical Services, Inc. Sustainability Profile
Avara Pharmaceutical Services, Inc., a leading provider in the pharmaceutical contract manufacturing industry, is headquartered in the United States. Founded in 2017, Avara has quickly established itself as a key player in the market, specialising in the production of high-quality pharmaceutical products and services. With operational facilities across North America and Europe, the company focuses on offering comprehensive solutions, including sterile and non-sterile manufacturing, packaging, and supply chain management. Avara's commitment to quality and innovation sets it apart, as it leverages advanced technologies and stringent regulatory compliance to meet the diverse needs of its clients. The company has achieved significant milestones, including successful partnerships with major pharmaceutical firms, solidifying its position as a trusted partner in the industry. With a strong emphasis on customer satisfaction and operational excellence, Avara Pharmaceutical Services continues to drive advancements in pharmaceutical manufacturing.
DitchCarbon Score
How does Avara Pharmaceutical Services, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avara Pharmaceutical Services, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Avara Pharmaceutical Services, Inc.'s reported carbon emissions
Avara Pharmaceutical Services, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As Avara Pharmaceutical Services does not inherit emissions data from a parent company or corporate family, it operates independently in terms of climate commitments. The lack of reported emissions and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing carbon emissions and setting ambitious targets to mitigate climate impact. Avara's current position highlights an opportunity for future engagement in sustainability practices and climate action.
How Carbon Intensive is Avara Pharmaceutical Services, Inc.'s Industry?
How Carbon Intensive is Avara Pharmaceutical Services, Inc.'s Location?
Avara Pharmaceutical Services, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Avara Pharmaceutical Services, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
